BVI Appoints Jim Hollingshead as President & Chief Executive Officer

BVI Appoints Jim Hollingshead as President & Chief Executive Officer

WALTHAM, Mass., Jan. 19, 2026 (GLOBE NEWSWIRE) -- BVI, a global leader in the ophthalmic device market, announced today the appointment of Jim Hollingshead as President & Chief Executive Officer. Hollingshead succeeds Shervin Korangy, who will continue to serve as…

BVI Announces Leadership Transition

BVI announced the appointment of Jim Hollingshead as President and Chief Executive Officer, succeeding Shervin Korangy, who will continue to serve as an advisor to BVI and will also begin a new role as senior advisor to TPG Capital. Mr. Hollingshead brings more than 20 years of experience leading and scaling medical device and life sciences companies. Most recently, he served as CEO of Insulet, a provider of insulin delivery. Prior to Insulet, M…